Webinar | Cardio-Oncology Working Group | Wednesday 23 September 2026 | 19.00 ( Greek Time )
Breast Cancer and the Heart: Redefining Cardiovascular Risk Across the Therapeutic Continuum
Webinar | Cardio-Oncology Working Group | Wednesday 23 September 2026 | 19.00 ( Greek Time )
Breast Cancer and the Heart: Redefining Cardiovascular Risk Across the Therapeutic Continuum
A New Era in Breast Cancer Treatment: From Therapeutic Innovation to Precision Oncology | Eleni Galani (Metropolitan Hospital )
Cardiotoxicity in Anthracyclines and HER2-Targeted Therapies: New Insights and an Old Question — Can We Truly Prevent and Reverse Cardiac Damage? | Llamedo MariaClara (Royal Brompton Hospital )
The changing landscape of breast cancer treatment: is cardiovascular toxicity still an afterthought? | Flora Stavridi (Hygeia Hospital)
The Role of the Cardio-Oncology Nurse in Managing Cardiotoxicity in Breast Cancer Patients | Reehal Priya (Royal Brompton Hospital)
Beyond LVEF and GLS: What Will the Next Generation of Cardiotoxicity Assessment Look Like? | Zarifis Ippokratis (Laikon General Hospital)
Session chairs | Helena-Diotima Michalopoulou Costas Thomopoulos (Laikon General Hospital )
Commentators | Eleni Angelopoulou, Dorothea Tsekoura, Peggy Kostakou, Sotiris Kalliampakos
When: Sep 23, 2026 19:00 Athens
Topic: Webinar | Cardio-Oncology Working Group | Wednesday 23 September 2026 | 19.00 ( Greek Time )
Join from PC, Mac, iPad, or Android:
https://us02web.zoom.us/j/81850912657?pwd=xPE8ynrgNiKNbPBHHRgDEiXoX8Sf36.1
Passcode:275967
